Pure Biologics S.A.

WSE:PUR Stock Report

Market Cap: zł62.8m

Pure Biologics Management

Management criteria checks 1/4

We currently do not have sufficient information about the CEO.

Key information

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenureno data
CEO ownershipn/a
Management average tenure3.3yrs
Board average tenureless than a year

Recent management updates

Recent updates

Here's Why We're Watching Pure Biologics Spólka Akcyjna's (WSE:PUR) Cash Burn Situation

Dec 06
Here's Why We're Watching Pure Biologics Spólka Akcyjna's (WSE:PUR) Cash Burn Situation

We Think Pure Biologics Spólka Akcyjna (WSE:PUR) Can Afford To Drive Business Growth

Aug 14
We Think Pure Biologics Spólka Akcyjna (WSE:PUR) Can Afford To Drive Business Growth

Will Pure Biologics Spólka Akcyjna (WSE:PUR) Spend Its Cash Wisely?

Apr 30
Will Pure Biologics Spólka Akcyjna (WSE:PUR) Spend Its Cash Wisely?

We Think Pure Biologics Spólka Akcyjna (WSE:PUR) Can Afford To Drive Business Growth

Jan 03
We Think Pure Biologics Spólka Akcyjna (WSE:PUR) Can Afford To Drive Business Growth

We're Interested To See How Pure Biologics Spólka Akcyjna (WSE:PUR) Uses Its Cash Hoard To Grow

Apr 21
We're Interested To See How Pure Biologics Spólka Akcyjna (WSE:PUR) Uses Its Cash Hoard To Grow

CEO

Pure Biologics has no CEO, or we have no data on them.

Leadership Team

NamePositionTenureCompensationOwnership
Filip Jelen
Co-founder & President of the Management Boardno datano data5.78%
PLN 3.6m
Romuald Harwas
CFO & Member of the Management Boardno datano data0.086%
PLN 53.7k
Pieter Spee
Chief Scientific Officer & Member of the Management Board3yrsno data0.027%
PLN 16.8k
Przemyslaw Dudek
Head of Information Technology4yrsno datano data
Ewelina Swiderek
Head of Project Management3.3yrsno datano data

3.3yrs

Average Tenure

Experienced Management: PUR's management team is considered experienced (3.3 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Waldemar Priebe
Member of Scientific Advisory Boardno datano datano data
Julia Bar
Member of Supervisory Boardno datano datano data
Mariusz Czekala
Member of Supervisory Boardno datano datano data
Jacek Otlewski
Member of Scientific Advisory Boardno datano datano data
Radoslaw Zagozdzon
Member of Scientific Advisory Boardno datano datano data
Konrad Rejdak
Member of Scientific Advisory Boardno datano datano data
Boguslaw Paradowski
Member of Scientific Advisory Boardno datano datano data
Katarzyna Suchoszek
Member of the Supervisory Boardless than a yearno datano data
Pawel Wisniewski
Vice Chairman of the Supervisory Board2yrsno datano data
Miroslaw Ciucman
Chairman of the Supervisory Boardless than a yearno datano data

1.0yrs

Average Tenure

Experienced Board: PUR's board of directors are not considered experienced ( 1 years average tenure), which suggests a new board.

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/02 05:46
End of Day Share Price 2025/01/02 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Pure Biologics S.A. is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Sylwia JaskiewiczDom Maklerski Banku Ochrony Srodowiska S.A.